Skip to main content
. Author manuscript; available in PMC: 2024 Jun 21.
Published in final edited form as: Bioconjug Chem. 2023 May 23;34(6):1130–1138. doi: 10.1021/acs.bioconjchem.3c00155

Table 1.

LD-TMAc targeted residues on bCAII

Probe Label Site Modification % SASA %

1 His3 95 ± 4 81
His63 50 ± 20 17.3

2 His3 70 ± 20 81
His63 60 ± 30 17.3
Ser181# 0.3 ± 0.2 30
Ser171/Thr172 0.09 ± 0.08 31.5$
Lys166* 0.06 ± 0.07 29.3

3 His3 80 ± 30 81
His63 70 ± 10 17.3
Ser72# 30 ± 1 74.8
His2* 2 ± 2 11.3
Ser28* 1 ± 0.5 0
Ser64* 0.5 ± 0.4 0.2
Ser171/Thr172 0.3 ± 0.1 31.5$
Lys250 0.2 ± 0.03 29.2
Lys44 0.1 ± 0.04 66.3

Based on 6 replicates.

Based on 3 replicates.

$

Ser171 and Thr172 average.

#

An outlier replicate removed at at 95% confidence.

*

Statistically significant at 90% confidence. The rest of the data is statistically significant at 95% confidence.